Radical versus partial nephrectomy for T1 non-clear cell renal cell carcinoma

被引:1
|
作者
Hu, Xu [1 ]
Wang, Yaohui [1 ]
Shao, Yanxiang [1 ]
Wu, Kang [1 ]
Tang, Yaxiong [1 ]
Ren, Shangqing [2 ]
Li, Xiang [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Urol, West China Med Sch,Inst Urol, Chengdu 610041, Peoples R China
[2] Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Robot Minimally Invas Surg Ctr, Chengdu 610072, Peoples R China
来源
EJSO | 2023年 / 49卷 / 08期
关键词
Radical nephrectomy; Partial nephrectomy; T1; Non-clear cell renal cell carcinoma; ONCOLOGICAL OUTCOMES; SURGICAL-MANAGEMENT; MORTALITY; TUMORS; RISK;
D O I
10.1016/j.ejso.2023.03.212
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Nephron-sparing surgery is the recommended surgical management of T1 renal cell carcinoma (RCC). However, non-clear cell RCC (nccRCC) is heterogeneous and included many histological types. Therefore, the present study was performed to compare radical nephrectomy (RN) versus partial nephrectomy (PN) in nccRCC. Materials and methods: Within the Surveillance, Epidemiology, and End Results registry (2000-2019), the patients with nccRCC were identified. Kaplan-Meier survival curve and the log-rank test were conducted. Univariate analysis and multivariate Cox regression analysis were performed to explore the prognostic factors. Results: A total of 7575 patients with nccRCC were included, of which papillary RCC (n = 5219) is the major histology. Kaplan-Meier plots and log-rank tests showed that nccRCC patients who underwent RN had significantly worse overall survival (OS) and cancer-specific survival (CSS) than those who received PN (all P < 0.05). Multivariate analysis also revealed that RN was significantly associated with poor OS and CSS in nccRCC patients. Stratified by histological types, the multivariate analysis also revealed that RN was significantly associated with poor OS in papillary and chromophobe (all P < 0.05). Besides, the multivariable analysis indicated that RN was associated with poor CSS in papillary RCC (P < 0.05). For other histology, the patients who received RN had a comparable survival to those who received PN. Conclusion: For patients with T1 nccRCC, our findings revealed that PN was not inferior to RN in OS and CSS. PN may be also the preferred option for T1 nccRCC, but more prospective studies are required to validate this finding. (c) 2023 Elsevier Ltd, BASO similar to The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
引用
收藏
页码:1519 / 1523
页数:5
相关论文
共 50 条
  • [41] Axial Abdominal Imaging after Partial Nephrectomy for T1 Renal Cell Carcinoma Surveillance
    Sorokin, Igor
    Canvasser, Noah E.
    Margulis, Vitaly
    Lotan, Yair
    Raj, Ganesh
    Sagalowsky, Arthur
    Gahan, Jeffrey C.
    Cadeddu, Jeffrey A.
    JOURNAL OF UROLOGY, 2017, 198 (05): : 1021 - 1026
  • [42] Renal cell carcinoma: The effect of targeted therapies on clear cell and non-clear cell histologies.
    Marascio, Joseph A.
    Rabatic, Bryan M.
    Zaenger, David
    Madden, Nicholas A.
    Marchan, Edward M.
    McDermott, David
    Misiura, Anne Kathryn
    Shaaban, Sherif
    Dasher, Byron G.
    Huang, Ke
    Pishgou, Mahboubeh
    Martin, William D.
    Aletan, Maryam
    Howington, Jed W.
    Albasheer, Ahmad M.
    Amoush, Ahmad
    Stewart, John G.
    Kong, Feng-Ming
    Ferguson, Catherine L.
    Mourad, Waleed F.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [43] Comparison of Radical Nephrectomy and Partial Nephrectomy for T1 Renal Cell Carcinoma: A Meta-Analysis (vol 101, pg 175, 2018)
    Liao Zhaolin
    Yang Chao
    UROLOGIA INTERNATIONALIS, 2019, 102 (02) : 247 - 247
  • [44] Morphological features and prognosis of non-clear cell renal cell carcinoma types
    Zakharava, V.
    Liatkouskaya, T.
    Kiselev, P.
    Cherstvoy, E.
    Lapec, A.
    VIRCHOWS ARCHIV, 2018, 473 : S335 - S336
  • [45] Pathology and systemic therapy of non-clear cell renal cell carcinoma: an overview
    Bergmann, Lothar
    Weber, Sarah
    Hartmann, Arndt
    Ahrens, Marit
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (11) : 1273 - 1286
  • [46] Systematic Review of Treatment of Metastatic Non-Clear Cell Renal Cell Carcinoma
    Brown, Jason R.
    Calaway, Adam
    Castle, Erik
    Garcia, Jorge
    Barata, Pedro C.
    KIDNEY CANCER, 2022, 6 (01) : 53 - 68
  • [47] EFFICACY AND SAFETY OF SUNITINIB IN PATIENTS WITH NON-CLEAR CELL RENAL CELL CARCINOMA
    Lee, J. -L.
    Ahn, J. -H.
    Park, S. H.
    Lim, H. Y.
    Lee, S. H.
    Kim, T. -M.
    Cho, Y. -M.
    Song, C.
    Hong, J. H.
    Kim, C. -S.
    Ahn, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 141 - 141
  • [48] PARTIAL NEPHRECTOMY VERSUS RADICAL NEPHRECTOMY FOR NON-METASTATIC RENAL CELL CARCINOMA: UTILIZATION TRENDS IN THE UNITED STATES
    Sun, Maxine
    Jeldres, Claudio
    Abdollah, Firas
    Liberman, Daniel
    Schmitges, Jan
    Djahangirian, Orchid
    Ismail, Salima
    Zorn, Kevin
    Shariat, Shahrokh F.
    Perrotte, Paul
    Karakiewicz, Pierre I.
    JOURNAL OF UROLOGY, 2011, 185 (04): : E219 - E219
  • [49] Non-clear cell renal cell carcinoma (nccRCC): A Brazilian experience.
    Yamamura, Rosely
    Rinck, Jose A.
    Fonseca Jesus, Victor Hugo
    Tavares, Monique Celeste
    de Castro Larclprete, Ana Luisa
    Iennaco, Pietro Schettlni
    Freitas, Heleno C.
    Cunha, Isabela Warneck
    Fanelli, Marcello Ferretti
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [50] The Role of Pazopanib in Non-Clear Cell Renal Cell Carcinoma: A Systematic Review
    Sneed, Gregory T.
    Lee, Sukdong
    Brown, Jamie N.
    Hammond, Julia M.
    CLINICAL GENITOURINARY CANCER, 2019, 17 (06) : 419 - 424